New York State Teachers Retirement System Raises Stock Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

New York State Teachers Retirement System boosted its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 6.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 28,343 shares of the medical instruments supplier's stock after purchasing an additional 1,777 shares during the quarter. New York State Teachers Retirement System owned about 0.12% of ICU Medical worth $4,398,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. State Street Corp raised its stake in ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock valued at $165,384,000 after purchasing an additional 77,506 shares in the last quarter. Geode Capital Management LLC raised its stake in ICU Medical by 9.6% during the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock valued at $99,687,000 after purchasing an additional 48,106 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in ICU Medical by 10.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier's stock valued at $54,868,000 after purchasing an additional 27,927 shares in the last quarter. WCM Investment Management LLC raised its stake in ICU Medical by 1.3% during the third quarter. WCM Investment Management LLC now owns 259,481 shares of the medical instruments supplier's stock valued at $45,272,000 after purchasing an additional 3,407 shares in the last quarter. Finally, Victory Capital Management Inc. raised its stake in ICU Medical by 0.5% during the third quarter. Victory Capital Management Inc. now owns 142,535 shares of the medical instruments supplier's stock valued at $25,973,000 after purchasing an additional 687 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

Insiders Place Their Bets

In other news, COO Christian B. Voigtlander sold 1,430 shares of the firm's stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Vivek Jain sold 1,373 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at $16,262,119.64. The trade was a 1.30 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,737 shares of company stock valued at $2,879,752. 6.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on ICUI. Jefferies Financial Group upgraded shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target on the stock in a report on Wednesday, December 11th. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a report on Wednesday, November 13th. KeyCorp increased their target price on shares of ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a report on Wednesday, November 13th. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Wednesday, November 20th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, ICU Medical presently has an average rating of "Moderate Buy" and a consensus target price of $199.67.

ICU Medical Stock Performance

Shares of ICU Medical stock traded down $5.73 during midday trading on Friday, hitting $157.42. The company had a trading volume of 159,367 shares, compared to its average volume of 190,778. The stock has a market cap of $3.85 billion, a price-to-earnings ratio of -34.45 and a beta of 0.63. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The company has a fifty day simple moving average of $160.82 and a 200 day simple moving average of $165.36. ICU Medical, Inc. has a 12-month low of $93.36 and a 12-month high of $196.26.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.